Participants are split on buying LLY shares. Some see strong long-term upside from upcoming drugs and plan to hold through volatility or add on dips, while others note much of the future success is already priced in and prefer waiting for a pullback or sticking with broad index funds instead.
What this discussion establishesWhether the stock should be purchased at current levels or avoided until after a split or correction versus treating it as a long-term hold regardless of short-term price moves.
Still openExact timing of any stock split, how much further the share price could rise, and whether competition will meaningfully cut into future profits.
Nothing here is advice.
Thinking about picking up some Lilly shares this week. With the new drug coming and the company already doing strong business, it seems like a solid idea that could run hard. Still, I am not great at this stuff.
Had the same idea. When the new drug launches it should move the stock a lot. Might be worth checking how earlier similar medicines performed before deciding.
Looking at forecasts the top target is quite high. I expect it will go past that and split eventually, so I am buying in. If it drops I will add a lot more at the bottom. Also looking at a couple big tech names that are all about AI.
As someone who invests a fair amount I like the idea of sticking to areas you already understand well. If you have spent time learning about these medicines then you already know the details and can judge the opportunity. I did something similar years ago with a tech name after seeing new features announced and it worked out well. The numbers on how many people could use these treatments suggest plenty of room left.
Much of the current price already assumes success with the next drug. Still looks like a reasonable long-term holding to me.
Hard to guess what they will charge for the new drug. Insurance probably will not cover it at first.
Waiting for a dip before adding shares for a long hold.
I was close to buying a large amount but changed my mind. The share price is high enough that even a big move does not feel worth it compared with other names I already own that keep rising steadily.
Buy the rumor and sell once the launch date is known because the price will probably drop after that.
You have to assume it keeps climbing and be ready to buy more if it falls. Average in over time. We probably know the company better than most outsiders. It is still a guess but dips are where smaller investors can add.
Besides growth they also pay a dividend that has been rising and should keep increasing. Any payout is better than none.
Bought earlier and added more on a recent dip. The next drug could be huge for them and the higher price target seems reachable. Also own shares in the main competitor and picked up a smaller company in the same space last week.
Between the two names, which looks stronger? One is already selling approved products while the other is still in trials.
Analysts say it is expensive now, yet the next drug should still help the price once approved. They have other candidates in development too. Bought a few shares but the high price means it needs a big move to matter. Another stock I own has been moving faster.
Holding a decent number of shares bought after seeing results from the new drug. Hard to picture anything else matching it soon, and a split would help.
Considered it until I saw how high the price already is.
I agree in principle but do not need the money and already have a large portfolio that performs well. Retired from a good job a couple years ago so I am in a fortunate spot.
The company will grow with or without our small purchases. If you invest you at least benefit from the same firm whose medicines will be copied elsewhere and then bought through other channels.
Been in the main competitor for over a year after seeing results with their medicine. They have other products beyond this class and are established, though I would not add heavily right now. The smaller company has more upside potential but is still unproven and could get acquired.
Another thing to watch is a once-monthly version from a big rival that is already in trials after they bought a smaller firm.
Put a small amount from a retirement account into both Lilly and the main competitor. I buy and hold and can afford to lose it. Treat single stocks like gambling and keep serious money diversified. Lilly has risen while the competitor has not, and I am still down overall on that one but have not sold.
Leaning toward buying a round number of shares and holding long term. Thanks for the input, lots of useful thoughts. A split before the next launch would be nice.
Funny to see someone on a grey-market forum considering shares in the company behind the drug everyone here is sourcing another way.
Where do people think these medicines actually come from?
Bought shares a couple years ago and it has been the best move I made recently. Wish I had bought more. They should pay a better dividend so holders do not have to sell shares to get any return.
All the information anyone has is already in the price. Hard to beat the market consistently, so broad index funds are simpler. Still, the thrill of picking a winner is real, so go ahead if you want.
The market for these medicines is already large and expanding. Most sales come through normal prescriptions rather than other channels, and that will likely continue as people trust their doctors and regulators.
I understand the point, just found the contrast interesting, like someone profiting from both sides of an issue.
Sounds good. Bought earlier at a much lower price and am unsure about adding now. Broad market funds might be safer. Time in the market matters more than timing.
Bought a few months ago and held through a dip, now slightly ahead. Big investors have probably already factored in approval of the next drug, but maybe not how big these medicines could become. Those actually using them understand the impact best.
That comparison does not fit. I own shares in car makers yet drive a different brand. No conflict, and these medicines are a growing field that will last because of diet trends. Fine to profit from it.
Extra money could make buying a few shares interesting to follow, but few beat the market picking stocks. Index funds have historically done well. Fund a Roth IRA first for the tax benefit. Bogleheads-style passive investing is worth looking into.
They should lead the injectable side for a couple years before rivals take share. Hard to predict prices. They focused on high prices over patients or loyalty, so when competition arrives there will be little goodwill left.
The company and similar firms act in ways that hurt regular people.
Hope for a split soon and would wait for it. Bought a large amount earlier at lower prices and feel set for retirement. Little downside overall.
Started later than I should have but kept adding through different jobs. Found a fund I like and have stayed with it, getting steady returns and managing taxes by taking some gains each year.
The future success is already built into the price. Just hold a broad index fund that already includes them.
True that few beat the market, yet everyday observations can still point to good companies. I have bought names after seeing their products in real life and done well. Bought this one after learning about the medicines they were bringing to market.
Spent a lot early on through official channels before switching to other sources, then bought shares in the company to recover some of that cost over time.
Might buy if the price comes back down. Other stocks look better right now anyway. No need to own this one just because you use the medicines.
Hard to see anyone catching them on new medicines or the stock until after 2030. After that competition should increase and prices may fall.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.